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This review summarizes and discusses virulence mechanisms whereby Porphyromonas gingivalis
can persist in the oral cavity. It is proposed that that the virulence of P. gingivalis is dependent, at
least in part, upon its ability to establish a complex host-pathogen molecular crosstalk which subverts
innate immunity. The sophisticated stealth and sabotage tactics used by P. gingivalis may additionally
benefit co-habiting organisms occupying the same niche
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1. Introduction
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Porphyromonas gingivalis is a gram-negative anaerobic and asaccharolytic rod that is widely
recognized as a predominant contributor to human periodontitis [1]. This is a polymicrobial
infection-driven inflammatory disease of the oral cavity, characterized by chronicity and
destruction of the tooth-supporting tissues. Moreover, P. gingivalis is implicated as an
accessory factor in certain systemic conditions, such as atherosclerotic heart disease or
aspiration pneumonia [2]. This pathogen is perhaps the most intensively studied oral organism
at the molecular level and its pathogenicity is attributed to a panel of potential virulence factors,
such as cysteine proteinases (gingipains), hemagglutinins, lipopolysaccharide (LPS), and
fimbriae, i.e., adhesive hair-like appendages emanating from the bacterial cell surface [3].
These and other virulence molecules are thought to coordinately enable P. gingivalis to
colonize or invade host tissues and secure critical nutrients [3].
P. gingivalis isamong the late colonizers of the oral cavity. Its colonization is influenced by
saliva, which serves as a vector for its transmission and initial entry into the oral environment.
Moreover, the salivary pellicle-coated tooth surfaces provide anchoring points for P.
gingivalis fimbriae, which additionally display binding affinity for certain early colonizing
bacteria [3]. These interactions presumably allow the pathogen to attach to a solid substratum,
thereby preventing its clearance by the salivary flow. Later in the infection process, P.
gingivalis may reach its eventual niche, i.e., the subgingival crevice (space between the free
gingiva and the tooth surface), by proliferation and spreading or by relocation of dislodged
bacteria. In addition to providing attachment sites, early colonizers, such as facultative
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anaerobic streptococci, may facilitate P. gingivalis colonization by reducing oxygen tension
to levels permissive for obligate anaerobic growth [3].
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However, the capacity of a pathogen to secure an appropriate niche and persist requires more
than simply possessing virulence factors for tissue adherence and nutrient procurement. To
establish a chronic infection in a hostile host environment, it is imperative that pathogens find
ways to evade or subvert host defense mechanisms aiming to eliminate them. Microbes which
successfully undermine the host response appear to preferentially target innate immunity [4],
partly because these are the defense mechanisms first encountered by the pathogens. In
addition, it should be appreciated that subversion of the innate response may also disable the
overall host response, given the instructive role of innate immunity in the development of
adaptive immunity [5]. In this review, I summarize and discuss molecular virulence
mechanisms of P. gingivalis (Table 1) and conclude that its pathogenicity is, at least in part,
dependent upon sophisticated stealth and sabotage tactics.

2. Staying alive in the crevice: interactions with epithelial cells and
neutrophils
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In addition to tooth surfaces, gingival sulcular epithelial cells offer additional attachment sites
for P. gingivalis in the crevicular region. However, P. gingivalis goes beyond simple adhesion
and actively invades and replicates within epithelial cells in vitro [3]. This strategy may allow
limited exposure to the extracellular space and could thus shield the pathogen from humoral
immune surveillance. Importantly, human crevicular epithelial cells do harbor intracellular P.
gingivalis, as well as other periodontal pathogens [6]. To extend its intracellular stay, P.
gingivalis inhibits gingival epithelial cell apoptosis, at least in part, by secreting an ATPhydrolyzing enzyme that suppresses ATP-induced apoptosis [7]. Although there may be
conditions under which P. gingivalis-infected gingival epithelial cells may succumb to
apoptosis (reviewed in ref. [8]), the pathogen may then implement “plan B” involving safe exit
and intercellular spreading [7]. This mechanism may potentially prolong its intracellular
lifestyle.
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Clinical periodontal observations have suggested that induction of inflammatory bone
resorption requires a minimum distance (< 2.5 mm) between the bone and the bacteria, and
this proximity may occur upon bacterial invasion of the gingival connective tissue (reviewed
in ref. [9]). To keep the bacteria at bay, neutrophils may chemotactically migrate into the
crevicular region for combined intracellular and extracellular killing. However, the ability of
gingival epithelial cells to induce interleukin (IL)-8 for chemoattraction and activation of
neutrophils is proactively inhibited by P. gingivalis in a cell-invasion dependent manner [10].
This so-called “local chemokine paralysis” is but one mechanism whereby P. gingivalis
attempts to suppress or delay neutrophil influx into its crevicular niche. Indeed, P. gingivalis
LPS does not induce endothelial cell expression of E-selectin and, furthermore, inhibits Eselectin upregulation by other periodontal bacteria [11]. Inhibition of E-selectin expression
results in diminished neutrophil adhesion to endothelial cells in vitro [11] and, presumably,
could suppress diapedesis and migration to sites of infection. In vivo, however, P. gingivalis
LPS does induce E-selectin expression, albeit at significantly lower levels compared to
enterobacterial LPS [12]. Apparently, the interactions of P. gingivalis with several cell types
in vivo may result in a different net effect than seen in vitro with isolated endothelial cells and,
eventually, neutrophils do migrate into the gingival crevicular region. However, the pathogen
possesses protective mechanisms to overcome the oxidative stress environment generated by
the neutrophil release of toxic reactive oxygen species [13]. In fact, P. gingivalis is exquisitely
resistant to killing by the oxidative burst [14]. The neutrophils may thus resort to non-oxidative
means in an effort to control P. gingivalis, although the pathogen seems to suppress at least
some of these mechanisms (e.g., degradation of the cathelicidin LL-37) [15]. The in vitro
Microbes Infect. Author manuscript; available in PMC 2010 May 1.
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opsonization of P. gingivalis with high-affinity specific antibody facilitates its killing by
neutrophils, although antibody production in periodontitis appears to be of low affinity and of
questionable protective value [16]. In conclusion, the neutrophil killing of P. gingivalis is, by
no means, an easy task, and not without collateral damage, since release of reactive oxygen
species can contribute to periodontal tissue destruction.

3. Fooling cell-mediated immunity
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Although the aforementioned intracellular sequestration tactics may protect P. gingivalis from
humoral immunity (e.g., antibodies), they may not confer protection against cell-mediated
immunity, which involves participation of natural killer cells, antigen-specific cytotoxic Tcells, and macrophages. Indeed, at least in principle, P. gingivalis-infected epithelial cells could
be killed by cytotoxic T cells or natural killer cells, the activation of which is positively
regulated by macrophage-derived IL-12 [17]. Intriguingly, P. gingivalis actively suppresses
the production of bioactive IL-12 (IL-12p70) in macrophages [18]. Specifically, P.
gingivalis interacts via its fimbriae with complement receptor-3 (CR3) leading to activation of
extracellular signal-regulated kinase 1/2, which in turn selectively inhibits IL-12 production
by at least 60% in vitro and in vivo [18] (Fig. 1). Even if this is a leaky mechanism, successfully
produced IL-12 may be functionally inactivated through proteolytic degradation, as is also the
case with a selected few more cytokines [15]. It is conceivable that the capacity of P.
gingivalis to inhibit or destroy IL-12 may suppress efficient activation of cytotoxic T cells and
natural killer cells, thereby favoring P. gingivalis survival in permissive cells, such as epithelial
cells. This notion has yet to be specifically addressed experimentally, e.g., by using P.
gingivalis-infected cells as targets in cytotoxicity assays.
On the other hand, there is evidence that CR3-dependent inhibition of IL-12 promotes P.
gingivalis survival [18], perhaps through regulatory effects on the production of IFN-!, which
is a potent activator of the macrophage microbicidal capacity [17]. Indeed, wild-type mice
elicit lower IL-12 and IFN-! levels and display impaired clearance of P. gingivalis systemic
infection compared to CR3-deficient mice [18]. Similar results were observed upon CR3
blockade with a specific antagonist which, moreover, inhibited the ability of P. gingivalis to
persist in the mouse oral cavity and to induce periodontal bone loss [18]. Thus, if left
uninhibited, P. gingivalis may cause disease via suppression of IFN-!-dependent cell-mediated
immunity. It is of interest to note here that, unlike classical enterobacterial LPS, the LPS of P.
gingivalis is a poor inducer of IFN-! even when it is administered in vivo [19]. P. gingivalis
therefore appears to prevent induction of IFN-! through both active and passive means.
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The potential of P. gingivalis to interfere with cell-mediated immunity is further supported by
its direct immunosuppressive effects on gene expression in CD4+ and CD8+ T cells in mice
[16]. Several studies in humans have also suggested that periodontal bacteria actively suppress
T cell-mediated immunity and, thereby, presumably contribute to periodontal lesion
development [16]. However, there is not, as yet, direct evidence for this notion from human
studies, which tend to be more correlative than mechanistic, due to several limitations including
important ethical considerations.

4. Modulation of the Toll-like receptor (TLR) response
In general, most virulence factors employed by pathogens for undermining the host response
are proteins. Unlike the relatively invariant microbe-associated molecular patterns (e.g.,
lipoteichoic acid, LPS, peptidoglycan), most of which perform essential microbial physiologic
functions, virulence proteins are responsible for microbial adaptation within a particular host
environment and are thus characterized by mutability [5]. However, the molecular
armamentarium used by P. gingivalis to manipulate the host response includes its LPS, i.e., a
structure that could be thought of as relatively invariable. In this regard, P. gingivalis expresses
Microbes Infect. Author manuscript; available in PMC 2010 May 1.
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a heterogeneous mixture of atypical lipid A structures, including species that trigger TLR2
signaling, weakly stimulate TLR4, or potently antagonize TLR4 activation [20]. Strikingly,
the P. gingivalis lipid A structure is regulated in response to microenvironmental hemin
concentrations which, in turn, are influenced by inflammation [21]. At a mechanistic level, it
is thought that high levels of hemin result in upregulation of deacylase activity which converts
penta-acylated lipid A into tetra-acylated lipid A [21]. Interestingly, P. gingivalis pentaacylated lipid A activates TLR4, whereas tetra-acylated lipid A antagonizes TLR4 [20]. It could
be speculated, therefore, that the regulated heterogeneity of its LPS structures may enable P.
gingivalis to manipulate the innate response and suppress TLR4-mediated immunity [20]. This
intriguing possibility awaits experimental confirmation, although it should be noted that
evasion of TLR4 activation has been associated with increased virulence of another organism.
Specifically, genetic modification of Yersinia pestis to produce a hexa-acylated lipid A
structure (and thus a strong TLR4 agonist) results in a completely attenuated strain, as opposed
to the highly virulent wild-type organism which synthesizes tetra-acylated lipid A with poor
TLR4-agonistic activity [22].
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Another possible mechanism to manipulate TLR signaling, at least in macrophages, involves
the ability of P. gingivalis LPS to markedly upregulate the IL-1R-associated kinase (IRAK)M, a negative regulator of the TLR signaling pathway [23]. This mechanism may contribute
to inhibition of the innate response, a notion that is certainly consistent with observations that
P. gingivalis LPS is a relatively poor inducer of IL-1" and TNF-# production compared with
E. coli LPS [3]. The P. gingivalis gingipains may also contribute, albeit indirectly, to reduced
TLR activation through their ability to degrade CD14, an important coreceptor of TLR2 and
TLR4 [15].
Unlike TLR4, TLR2 (in association with its signaling partner TLR1) can readily recognize and
respond to P. gingivalis. However, the pathogen can manipulate TLR2 signaling by instigating
a molecular cross-talk between this TLR and the CXC-chemokine receptor 4 (CXCR4) [24]
(Fig. 1). Specifically, the binding of P. gingivalis fimbriae to CXCR4 induces cAMPdependent protein kinase A signaling, which in turn suppresses TLR2/1-mediated NF-$B
activation and induction of nitric oxide production. The potential importance of this mechanism
is supported by in vivo observations. Indeed, mice treated with a specific CXCR4 antagonist
display increased production of nitric oxide and enhanced ability to control a systemic infection
with P. gingivalis compared to control mice [24]. This and the above cited examples suggest
that the manipulation of the TLR response is a likely mechanism whereby P. gingivalis may
promote its adaptive fitness in the mammalian host.

5. Scoffing at complement or making good use of it?
NIH-PA Author Manuscript

P. gingivalis can suppress all three mechanisms of complement activation, i.e., the classical,
lectin, and alternative pathways, through proteolytic degradation of key complement
components such as the C3 [15]. As a further precaution, the pathogen hijacks a physiological
inhibitor of complement activation. Specifically, the C4b-binding protein is captured on the
bacterial cell surface and thereby interferes with the activation of the complement cascade
[15]. These subversive activities are mediated by the gingipains and particularly the Argspecific enzymes. When gingipain-deficient mutants are exposed to human serum, active
complement fragments are readily deposited on the bacterial surface; strikingly, however, the
mutants maintain full viability as does the wild-type organism [25]. This observation was
conclusively attributed to expression of a surface anionic polysaccharide which confers
exquisite resistance to complement-mediated lysis [25]. However, as is often the case, new
discoveries only breed new questions: What is the survival advantage of being capable to inhibit
complement when the pathogen is intrinsically resistant to complement-mediated killing? A
possible explanation is that this apparent redundancy seen in in-vitro experiments may actually

Microbes Infect. Author manuscript; available in PMC 2010 May 1.
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represent an essential combination of strategies for effective protection in vivo. Another
possibility could be that the surface anionic polysaccharide is present only in selected strains
of P. gingivalis. Although this structure was initially identified in W50 (a Type IV fimA strain)
and 381 (a Type I fimA strain) [25], subsequent work has shown that a specific monoclonal
antibody is reactive with a variety of distinct strains, suggesting that the anionic polysaccharide
is a general feature of P. gingivalis (M.A. Curtis, personal communication). Given that this
surface glycan provides inherent protection, an alternative interpretation is that P. gingivalis
has evolved the ability to inhibit complement activation, not for its own protection, but for the
benefit of companion species sharing the same subgingival niche. This seemingly altruistic
behavior may be justified in terms of evolutionary survival advantage for P. gingivalis, since
the benefiting bacteria appear to reciprocate. In this regard, the pathogen depends on other
members of the mixed-species periodontal biofilm for enhanced colonization and full
expression of virulence [26].

NIH-PA Author Manuscript
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Intriguingly, the overall strategy of P. gingivalis may not aim to simply inactivate the
complement cascade, but also to actively exploit specific aspects of it for interfering with innate
immunity in general. In this regard, P. gingivalis proactively generates an active complement
fragment through direct action of its Arg-specific gingipains. Specifically, the pathogen causes
limited degradation of C5 resulting in functional C5a, i.e., it is chemotactically active as is the
physiologically produced C5a anaphylatoxin [27]. Moreover, P. gingivalis Arg-specific
gingipains may indirectly generate functional C5a through their ability to activate prothrombin
to form thrombin [28]. Thrombin, in turn, generates biologically active C5a by acting as a C5
convertase [29]. It is quite safe to assume that a successful pathogen would not likely engage
in activities that may promote host defense, unless the net outcome offers some survival
advantage. It, therefore, becomes important to understand and interpret this superficially
suicidal behavior of P. gingivalis which appears to generate weapons (C5a) for the host. C5a
interacts with two receptors, the classical C5a receptor (C5aR; CD88) and the recently
identified and modestly characterized C5L2, although it is the interaction with C5aR which
mediates the anaphylactic and chemotactic activities of C5a [30]. Interestingly, C5aR-induced
signaling in macrophages interferes with TLR4-mediated production of IL-12, and this leads
to suppression of Th1 cell-mediated immunity in vitro and in vivo [31,32]. It could, therefore,
be speculated that P. gingivalis causes the generation of active C5a fragment for inhibiting Th1
cell-mediated immunity. Nevertheless, P. gingivalis has already at least one mechanism for
promoting its survival through inhibition of IL-12 and IFN-! in vivo, which is dependent upon
CR3 hijacking [18] (see also above). However, if C5a is exploited by P. gingivalis for the same
reason, this may not be a redundant but rather a complementary mechanism as the interaction
of CR3 with P. gingivalis does not fully inhibit IL-12 production [18]. The possibility for C5a
exploitation is also supported by observations that the intracellular survival of P. gingivalis in
phagocytes is promoted in the presence of C5a, although the underlying mechanism is yet
unclear (our unpublished observations). Future studies will determine whether P. gingivalis
displays a purely defensive agenda in facing the complement system, or whether it proactively
exploits specific complement components for undermining other innate immune mechanisms.

6. Macrophage lipid rafts: Safe portals for P. gingivalis?
Certain intracellular pathogens, such as Salmonella typhimurium, Shigella flexneri, and
Mycobacterium spp. enter macrophages through lipid rafts, i.e., cholesterol- and sphingolipidenriched membrane microdomains which partition receptors for various cellular signaling and
trafficking processes [33]. The “choice” of lipid rafts as portals of pathogen entry might appear
ironic, given their role in host defense as signaling platforms for TLRs and other immune
receptors [34]. Nevertheless, lipid rafts appear to be targeted by pathogens. It is thought that
the lipid-raft route of microbial uptake affords protection from the intracellular degradative
lysosomal pathway (reviewed in ref. [33]). This is attributed to the notion that internalized rafts

Microbes Infect. Author manuscript; available in PMC 2010 May 1.
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do not readily fuse with late endosomes and lysosomes [35], in sharp contrast to opsonic
phagocytosis through Fc receptors, which is raft-independent and readily leads to pathogen
degradation [33]. Recent evidence suggests that P. gingivalis may also exploit lipid rafts for
immune evasion. Specifically, the pathogen interacts directly with lipid rafts on the cell surface
of macrophages and uses them to enter the cells in a way that increases its survival potential
[36]. Disruption of lipid rafts by cholesterol depletion partially suppresses the uptake of P.
gingivalis, which however now traffics preferentially to the lysosomes and is killed [36]. These
data suggest that P. gingivalis-containing phagosomes originating from lipid rafts have a more
favorable intracellular fate than phagosomes emanating from non-raft regions of the cell
membrane.
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However, what remains uncertain is whether P. gingivalis entry via lipid rafts is sufficient per
se to confer protection from lysosomal trafficking and killing. Alternatively, the passing of P.
gingivalis from lipid rafts may offer an opportunity to exploit or subvert raft-mediated
signaling. In this context, mycobacteria appear to exploit lipid rafts in a very specific way.
Indeed, to prevent post-phagocytosis killing, mycobacteria induce recruitment of a coat protein
designated TACO (tryptophane aspartate-containing coat protein; also known as coronin-1)
which associates in a cholesterol-dependent way with the phagosomalmembrane and prevents
its fusion with lysosomes [33]. Arguably, CR3 may be at least one of potential receptors
exploited by P. gingivalis in lipid rafts. First, CR3 is recruitable to lipid rafts upon activation
with appropriate microbial stimuli, including P. gingivalis fimbriae [34]. Second, CR3independent phagocytosis of P. gingivalis (due to CR3 blockade or genetic deficiency)
dramatically inhibits its intracellular survival compared to conditions that allow CR3-mediated
entry [37]. Mechanistically, this could be accounted for by observations that CR3 is not linked
to vigorous microbicidal mechanisms [4]. This, however, begs the question of why the host
expresses an Achilles’ heel type of phagocytic receptor. A plausible explanation is that, under
physiologic conditions, CR3 is heavily committed with phagocytosis of apoptotic cells
(reviewed in ref. [18]). Since apoptotic cells are not normally recognized as danger, induction
of a vigorous host response is not justified, and P. gingivalis aptly exploits this CR3-associated
loophole (Fig. 1).
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Although the lipid raft route of entry promotes the intracellular survival of P. gingivalis, the
pathogen does not seem capable of replicating within macrophages [36,37] as it does in
epithelial or endothelial cells [3,38]. This raises questions as to the biological significance of
this entry mechanism. An intriguing possibility may be suggested in the context of the
periodontitis-atherosclerosis connection [2] and the observation of viable P. gingivalis in
atherosclerotic plaques [39]. Conceivably, the ability of P. gingivalis to persist within
macrophages may allow this organism to exploit them as “Trojan horses” for relocation to
systemic tissues and subsequent infection of permissive cells (e.g., endothelial cells). Although
this is a hypothetical scenario at the moment, the capacity of P. gingivalis for cell exit and
infection of new host cells is well documented [7].

7. Stealth attack or overt aggression?
As discussed above, P. gingivalis attempts to downregulate or even deregulate the host
response using a variety of documented or suspected strategies. However, the pathogen does
induce inflammatory reactions and, after all, it is strongly associated with a chronic disease
(periodontitis) where tissue damage is mostly mediated by inflammatory mechanisms. This
represents an apparent paradox begging for explanation (Table 2). It could be speculated,
however, that mechanisms for immunosuppression or promotion of inflammation may be
employed under different conditions, depending on whether inflammation is beneficial or not
for P. gingivalis. For example, in the early stages of infection, P. gingivalis may suppress host
defense to facilitate its colonization of the subgingival crevice. At later stages, when a relatively
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recalcitrant pathogenic biofilm has been established, stimulation of inflammatory serum
exudate may contribute to an increased demand for nutrients, such as hemin, a source of
essential iron. Although this is an interesting hypothesis, it is currently unknown whether and
how this strategy could be coordinated. Nevertheless, the observation that P. gingivalis alters
the lipid A structure of its LPS [21], suggests that, at least in principle, the proinflammatory
potential of this pathogen is a regulatable activity.
Another possibility is that P. gingivalis may not induce a wholesale immunosuppression but
rather exploits selective signaling pathways in ways that undermine the ability of the host to
eliminate it; in this scenario, pathways eliciting nonproductive inflammation stay intact and
cumulatively contribute to periodontal tissue destruction. For example, the interaction of P.
gingivalis with CR3 inhibits induction of IL-12, which would contribute to its clearance [18],
but promotes TNF-# [18], which contributes to periodontal bone loss [9]. Still another
possibility, which might appear heretical, is that periodontal tissue destruction may
predominantly be the result of inflammation caused by endogenous inducers of inflammation,
such as breakdown products of the extracellular matrix [40], which can readily be generated
by P. gingivalis [15].
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The putative evasion tactics of P. gingivalis contrast it with aggressive pathogens which engage
in “open war” with the host, but also with most commensals, which homeostatically stimulate
immune responses under an “armed peace” deal with the host. The relationship of P.
gingivalis with the host could be equated to a “guerilla war” using stealth and/or sabotage
tactics. In that sense, Aggregatibacter actinomycetemcomitans, another important periodontal
pathogen, appears to be a more overt pathogen than P. gingivalis. While P. gingivalis inhibits
induction of IL-12 and IFN-!-dependent cell-mediated immunity [18], A.
actinomycetemcomitans is a powerful inducer of IL-12 and IFN-! [41]. This activity is
predominantly dependent on the LPS of A. actinomycetemcomitans which does not appear to
modify the TLR reactivity of its lipid A as, by contrast, occurs in P. gingivalis (discussed
above). Moreover, contrary to the P. gingivalis-instigated “local chemokine paralysis” [10],
A. actinomycetemcomitans actually induces production of IL-8 and expression of intercellular
adhesion molecule-1 in gingival epithelial cells [42]. Therefore, far from inhibiting, A.
actinomycetemcomitans appears to stimulate the recruitment of neutrophils. Whereas P.
gingivalis may survive by suppressing the initiation of the host response, A.
actinomycetemcomitans may promote its persistence by elaborating powerful toxins (e.g.,
leukotoxin and cytolethal distending toxin) capable of killing innate and adaptive immune
effector cells (reviewed in ref. [43]). These contrasting behaviors do not rule out synergistic
enhancement of virulence through combined immunosuppression of selective pathways and
direct killing of effector cells, which is likely to happen in polymicrobial infections like
periodontitis.
Despite evidence suggesting an immunosuppressive role for P. gingivalis, is it possible that
this species, like the ancient Roman god Janus, displays two faces? One that is sneaky and
stealthy and another of a more aggressive character, each represented by distinct strains? In
this regard, it should be noted that most studies focusing on molecular virulence mechanisms
of P. gingivalis have predominantly used Type I fimbriated strains (e.g., 33277 and the related
381). These studies collectively suggest that Type I fimbriae play critical roles in colonization,
cell invasion, and subversion of the host response [3,24]. However, the fimA gene, which
encodes for the major fimbrillin subunit, exhibits considerable sequence diversity and P.
gingivalis fimbriae have been classified into six genotypes (I–V and Ib) [44]. Recent functional
comparative studies have shown that Type II fimbriated P. gingivalis (Pg-II) is dramatically
more proinflammatory than Pg-I, both in vitro and in vivo [44,45]. Moreover, in systemic
models of disseminated infection, Pg-II (as well as Pg-IV) are considerably more aggressive
and cause more tissue damage than Pg-I [46,47]. This contrasts with findings that Pg-I is more
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virulent than Pg-II in the mouse periodontitis model, where colonization of the oral cavity is
a formidable challenge and may be compromised if the implanted strain elicits a vigorous host
response (our unpublished observations). The above discussed FimA-based virulence
differences still hold when the Type I and II fimA genes were exchanged between Pg-I and PgII strains, resulting in two swap mutants expressing the heterologous FimA [45](and our
unpublished data), suggesting that the type of fimbriae dictate the behavior of P. gingivalis to
a significant degree.
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It is conceivable that different P. gingivalis strains may have developed distinct virulence
strategies to cope with the mammalian host. For example, certain strains, such as Pg-I, may
not afford to be overtly aggressive due to lack of protective capsule (in this regard, most PgII strains are encapsulated while Pg-I strains like 33277 and 381 are not [48]). Overt pathogens
may often succeed by overwhelming innate defenses, whereas organisms lacking such capacity
may have instead evolved stealth strategies to evade elimination by the immune system. A
recent study has identified a great number of P. gingivalis mobile genetic elements which
appear to be involved in extensive genome rearrangement and generation of many strainspecific protein-coding sequences [49]. It is intriguing to speculate that the virulence diversity
of different P. gingivalis strains may work in synergy to promote the survival of the species.
In this regard, a single periodontal site can harbor multiple P. gingivalis sequence types and
different fimA genotypes appear to colonize the same site [50]. It is conceivable, although it
remains to be established, that the combination of immunosuppressive activities and frontal
attack strategies by different strains may be more effective for P. gingivalis survival than when
either strategy acts alone.

8. Concluding remarks
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The published information reviewed here suggests that, at least in principle, P. gingivalis has
evolved a sophisticated program of tactics to evade multiple checking points of the innate
immune system. Through its gingipains, fimbriae, LPS, or other factors, P. gingivalis appears
capable to manipulate innate recognition mechanisms (Fig. 1), find refuge in relatively safe
environments, evade or subvert complement, and in general proactively modify the innate
response in ways that favor its persistence in the host. Some of the putative mechanisms may
simply be potentialities, although at least some have been confirmed in vivo in animal models
(Table 1). However, it is now appreciated that P. gingivalis is genetically diverse and includes
strains that appear to thrive on alternative, more direct offensive tactics (Table 2; point 4).
Whether “immunosuppressive” and “aggressive” strains fight for survival independently or
combine their diverse tactics has yet to be addressed experimentally. Of course, periodontitis
is not a mono-infection but rather a polymicrobial disease caused by a pathogenic biofilm
residing in the subgingival region. Although P. gingivalis is but one of many periodontal
pathogens, its presence may endow the whole biofilm with a panoply of critical virulence
attributes; these may additionally promote the survival of other bacteria in the mixed species
biofilm of the periodontal pocket. Understanding how P. gingivalis evades, subverts, or attacks
the immune system is of paramount importance to understanding its role in periodontitis and
associated systemic diseases and developing effective intervention therapeutic strategies.
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Fig. 1. Model of P. gingivalis exploitation of innate immune receptors for undermining host defenses
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P. gingivalis is predominantly recognized by the TLR2/1 heterodimer [34]. Through its
fimbriae, the pathogen binds CXCR4 which cross-talks with and suppresses the TLR2/1induced TIRAP/MyD88-mediated antimicrobial pathway [24]. The mechanism involves
CXCR4-induced activation of cAMP-dependent protein kinase A (PKA) which suppresses
NF-$B activation and induction of proinflammatory cytokines and antimicrobial molecules,
such as the inducible nitric oxide synthase (iNOS). These inhibitory effects promote P.
gingivalis survival in vitro and in vivo [24]. The CXCR4 mechanism does not however inhibit
the P. gingivalis-induced inside-out signaling, which proceeds via phosphatidylinositol 3kinase (PI3K) and cytohesin-1 and activates the high-affinity conformation of CR3 [18,37]
(and unpublished data). Intriguingly, P. gingivalis interacts with activated CR3 and is thereby
internalized; this is a relatively safe portal of entry since CR3 is not linked to vigorous
microbicidal mechanisms [4,36]. Moreover, the P. gingivalis-CR3 interaction induces outsidein signaling, which via extracellular signal-related kinase 1/2 (ERK1/2) downregulates IL-12
p35 and p40 mRNA expression [18], possibly through ERK1/2 suppression of IRF-1 and
ICSBP transcription factors [31]. At the protein level, the outcome is reduced production of
bioactive IL-12 resulting in impaired immune clearance of P. gingivalis in vivo [18].
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Table 1

Molecular virulence mechanisms of P. gingivalis
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Mechanisms

Key virulence factor

Outcome

Type of evidence

Refs.

Structural
modification of the
lipid A structure of
LPS; conversion of
penta-acylated lipid
A (TLR4 agonist) to
tetra-acylated lipid
A (TLR4
antagonist)

Deacylase

Suppression of TLR4
activation

in vitro

[20,21]

Upregulation of
negative regulators
of TLR signaling
(IRAK-M) in
monocytes

LPS

May contribute to inhibition
of the innate response

in vitro

[23]

Induction of TLR2
inside-out signaling
for CR3 activation
in macrophages

Fimbriae

in vitro& in vivo

[18,37]

Instigation of
CXCR4/TLR2
cross-talk in
macrophages

Fimbriae

Suppression of immune
clearance of bacteria

in vitro & in vivo

[24]

Degradation of
essential TLR
coreceptors
(CD14), cytokines
(IL-12, IL-1", IL-6,
IFN-!), or
antimicrobial
peptides (e.g.,
LL-37)

Gingipains

May suppress innate
immunity

in vitro

[15]

Intrinsic resistance
to the lytic action of
complement

Cell-surface anionic polysaccharide

Resistance to complementmediated killing

in vitro

[25]

Inhibition of
complement
activation
(classical, lectin,
and alternative
pathways)

Gingipains (particularly Arg-specific)

Inhibition of deposition of
active complement
fragments on the bacterial
cell surface

in vitro

[15]

Lipid raft-mediated
entry into
macrophages

Not determined 1

Reduced intracellular killing

In vitro

[37]

Counteraction of
oxidative damage

Rubrerythrin (nonheme iron protein),
alkyl hydroperoxide reductase, FeoB2
(ferrous iron transport protein)

Resistance to environmental
oxidative stress and
oxidative killing by
phagocytes

In vitro and in
vivo 2

[13,14]

ATP hydrolysis

Nucleoside diphosphate kinase

Suppression of ATP-induced
epithelial cell apoptosis;
enhanced intracellular
persistence

in vitro

[7]

Inhibition of IL-8
production by
epithelial cells

Requires cell invasion

Possible suppression or
delay of neutrophil influx

in vitro

[10]

Lack of E-selectin
induction;
inhibition of Eselectin

LPS

Diminished neutrophil
adhesion to endothelial cells;
presumably suppressed

in vitro; not
confirmed in vivo
3

[11,12]

a.

CR3-dependent
inhibition of
IL-12

b.

CR3-mediated
entry leading to
enhanced
survival
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Key virulence factor

upregulation by
other periodontal
bacteria
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Immunosuppressive
effects on gene
expression in CD4+
and CD8+ T cells

Outcome

Type of evidence

Refs.

In vivo

[16]

migration to sites of
infection.
Outer-membrane antigens

May suppress cell-mediated
immunity 4

1

Only wild-type bacteria used; surface structures such as fimbriae or LPS which interact with lipid raft-associated receptors may be important.

2

In vivo evidence obtained for ruberythrin; in vivo testing did not support a role for alkyl hydroperoxide reductasel; FeoB2 not tested in vivo.

3

Although P. gingivalis LPS did induce E-selectin expression in vivo, this was a relatively weak activity compared to enterobacterial LPS.

4

Cell-mediated immunity may also be inhibited through inhibition of IL-12 and IFN-!, as indicated above.
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Table 2

Reconciliation of P. gingivalis (Pg) immunosuppressive phenotype with chronic inflammation.
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Proposed mechanisms

Theoretical basis* [ref.]

1

Pg regulates its proinflammatory potential, at least in part by
altering its lipid A structure [21].

2

Regulation of proinflammatory potential according to
circumstances.
a.

Early-stage immunosuppression to facilitate
colonization.

b.

Later-stage inflammation to meet increased demand
for nutrients (e.g., hemin in inflammatory exudate).

Selective immunosuppression.
a.

Killing mechanisms are inhibited

b.

Nonproductive inflammation that fails to eliminate Pg
remains intact and contributes to tissue destruction.

Pg-activated CR3 inhibits IL-12 but not TNF-# [18]. IL-12
promotes Pg killing[18], whereas TNF-# induces destructive
inflammation [9].

NIH-PA Author Manuscript

3

Tissue destruction is predominantly caused by endogenous
inducers of inflammation.

Breakdown products of extracellular matrix are potent
inflammatory stimuli [40], and Pg degrades extracellular
matrix [15].

4

Janus-like doubled-faced character of the Pg species represented
by distinct strains:

Pg fimA displays genetic diversity which determines, to a large
degree, proinflammatory and virulence properties of fimbrial
genotypes [44,45].
Numerous Pg mobile genetic elements appear to generate a
plethora of strain-specific protein-coding sequences [49].
Virulence diversity may work in synergy to promote the
survival of the Pg species.

a.

Type I FimA strains may be stealthy.

b.

Type II or IV FimA strains may be overtly aggressive.

*

Does not fully explain the mechanism but involves documented examples which offer plausibility.
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